Search

Search Bar
01/06/2022 The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours
Lopez, F, Shah, JP, Beitler, JJ, Snyderman, CH, Lund, V, Piazza, C, Makitie, AA, Guntinas-Lichius, O, Rodrigo, JP, Kowalski, LP, Quer, M, Shaha, A, Homma, A, Sanabria, A, Ferrarotto, R, Lee, AWM, Lee, VHF, Rinaldo, A, Ferlito, A. The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours. ADVANCES IN THERAPY. 2022; 39(6)DOI:10.1007/s12325-022-02080-x. PMID:35352310. IF:3.800(Q2/4D).
01/05/2022 Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC
Meler-Claramonte, C, Aviles-Jurado, FX, Vilaseca, I, Terra, X, Bragado, P, Fuster, G, Vintro, XL, Camacho, M. Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC. Cancers. 2022; 14(9)DOI:10.3390/cancers14092259. PMID:35565388. IF:5.200(Q2/3D).
01/05/2022 Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4(+) head and neck squamous cell carcinoma tumors
Rioja-Blanco E., Arroyo-Solera I., Álamo P., Casanova I., Gallardo A., Unzueta U., Serna N., Sánchez-García L., Quer M., Villaverde A., Vázquez E., Mangues R., Alba-Castellón L., León X.. Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4(+) head and neck squamous cell carcinoma tumors. Acta Pharmaceutica Sinica B. 2022; 12(5)DOI:10.1016/j.apsb.2021.09.030. PMID:35646535. IF:14.500(Q1/1D).
01/04/2022 A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model
Rioja-Blanco, E, Gallardo, A, Arroyo-Solera, I, Alamo, P, Casanova, I, Unzueta, U, Serna, N, Sanchez-Garcia, L, Quer, M, Villaverde, A, Vazquez, E, Leon, X, Alba-Castellon, L, Mangues, R. A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model. Pharmaceutics. 2022; 14(4)DOI:10.3390/pharmaceutics14040887. PMID:35456719. IF:5.400(Q1/2D).